미국의 혈관 접근 기기 시장 규모, 점유율, 제품별 동향 분석 리포트, 부문별 예측(2025-2030년)

U.S. Vascular Access Devices Market Trends:

The U.S. vascular access devices market size was estimated at USD 1.40 billion in 2024 and is expected to grow at a CAGR of 5.6% from 2025 to 2030. The market growth is driven by the increasing prevalence of chronic diseases and the growing need for medical procedures that require vascular access. As healthcare providers continue to seek efficient solutions for delivering medications, fluids, and nutrients, the demand for innovative vascular access devices is expected to rise. Additionally, advancements in technology, such as the development of antimicrobial coatings and the integration of smart technologies in vascular access devices, contribute to enhancing patient safety and improving clinical outcomes.

The rising CVD cases in the U.S. are expected to fuel the market growth. According to the American Heart Association article published in January 2024, in the U.S., CVD results in about 2,552 deaths each day. CVD patients require long-term treatments involving medications and fluids, often administered through vascular access devices like central venous catheters (CVCs) and peripherally inserted central catheters (PICCs). This growing demand for cardiovascular care is a key driver for the market, as these devices play a critical role in managing CVD effectively

The growth of the U.S. vascular access devices industry is also driven by rising use of vascular access devices among pediatric patients. For instance, in January 2024, the Population Reference Bureau had projected that the American population aged 65 and over would expand from 58 million in 2022 to 82 million by 2050, reflecting a 47% increase. Additionally, it was anticipated that the share of the total population belonging to this age bracket would grow from 17% to 23%. Older adults are easily susceptible to infectious diseases and need hospital treatment by administering parenteral nutrition (PN), which helps maintain strength, energy, and hydration.

In addition, increased cancer cases and chemotherapy demand is anticipated to drive the growth of the market. According to the National Cancer Institute, in 2024, it is projected that approximately 2,001,140 new cancer cases will be diagnosed in the United States, with an estimated 611,720 individuals expected to die from the disease. Cancer treatment, particularly chemotherapy, plays a crucial role in managing the condition. According to a Health Cost Institute article published in March 2023, nearly 1 million people in the U.S. undergo chemotherapy each year. Most of these treatments are administered via infusion or injection, often requiring patients to visit a physician's office or hospital outpatient department.

The widespread use of infusion therapies in cancer treatment underscores the critical role of vascular access devices, such as peripherally inserted central catheters (PICCs) and central venous catheters (CVCs), in delivering chemotherapy. This growing demand for oncology care is drives the North American vascular access devices market, as these devices are essential for ensuring safe, effective, and long-term access to the bloodstream for cancer patients undergoing treatment.

U.S. Vascular Access Devices Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. vascular access devices market report based on product:

• Product Outlook (Revenue, USD Billion, 2018 - 2030)
• Central Venous Catheters (CVC)
  • Tunneled CVC
  • Non-Tunneled CVC
• Peripherally Inserted Central Catheter (PICCs)
  • Power Injected
  • Standard

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Vascular Access Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing prevalence of cardiovascular diseases
    • 3.2.1.2. Increasing need for vascular access devices in oncology
    • 3.2.1.3. Technological advancements in vascular access devices
    • 3.2.1.4. Rising use of vascular access devices among pediatric patients
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulations and product recalls
    • 3.2.2.2. Risks associated with catheter usage
• 3.3. U.S. Vascular Access Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pipeline Analysis

Chapter 4. U.S. Vascular Access Devices Market: Product Estimates & Trend Analysis

• 4.1. Global U.S. Vascular Access Devices Market: Product Dashboard
• 4.2. Global U.S. Vascular Access Devices Market: Product Movement Analysis
• 4.3. Global U.S. Vascular Access Devices Market by Product, Revenue
• 4.4. Central Venous Catheters (CVC)
  • 4.4.1. Central Venous Catheters (CVC) market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.2. Tunneled CVC
    • 4.4.2.1. Tunneled CVC market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.3. Non-Tunneled CVC
    • 4.4.3.1. Tunneled CV market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.5. Peripheral Parenteral Nutrition (PPN)
  • 4.5.1. Peripheral parenteral nutrition (PPN) market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5.2. Power Injected
    • 4.5.2.1. Power Injected market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5.3. Standard
    • 4.5.3.1. Standard market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Competitive Landscape

• 5.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 5.2. Company/Competition Categorization
• 5.3. Vendor Landscape
  • 5.3.1. List of key distributors and channel partners
  • 5.3.2. Key customers
  • 5.3.3. Key company market share analysis, 2024
• 5.4. Company Profiles
  • 5.4.1. BD
    • 5.4.1.1. Company overview
    • 5.4.1.2. Financial performance
    • 5.4.1.3. Product benchmarking
    • 5.4.1.4. Strategic initiatives
  • 5.4.2. Teleflex
    • 5.4.2.1. Company overview
    • 5.4.2.2. Financial performance
    • 5.4.2.3. Product benchmarking
    • 5.4.2.4. Strategic initiatives
  • 5.4.3. B Braun
    • 5.4.3.1. Company overview
    • 5.4.3.2. Financial performance
    • 5.4.3.3. Product benchmarking
    • 5.4.3.4. Strategic initiatives
  • 5.4.4. Medical Components, Inc
    • 5.4.4.1. Company overview
    • 5.4.4.2. Financial performance
    • 5.4.4.3. Product benchmarking
    • 5.4.4.4. Strategic initiatives
  • 5.4.5. Vygon SA
    • 5.4.5.1. Company overview
    • 5.4.5.2. Financial performance
    • 5.4.5.3. Product benchmarking
    • 5.4.5.4. Strategic initiatives
  • 5.4.6. Medtronic/Mozarc Medical
    • 5.4.6.1. Company overview
    • 5.4.6.2. Financial performance
    • 5.4.6.3. Product benchmarking
    • 5.4.6.4. Strategic initiatives
  • 5.4.7. Merit Medical/AngioDynamics
    • 5.4.7.1. Company overview
    • 5.4.7.2. Financial performance
    • 5.4.7.3. Product benchmarking
    • 5.4.7.4. Strategic initiatives
  • 5.4.8. Others
    • 5.4.8.1. Company overview
    • 5.4.8.2. Financial performance
    • 5.4.8.3. Product benchmarking
    • 5.4.8.4. Strategic initiatives